Biogen exercises option with denali to develop and commercialize antibody transport vehicle program targeting amyloid beta

Program uses denali's antibody transport vehicle (atv) technology to cross the blood-brain barrier (bbb) and aims to increase target engagement program uses denali's antibody transport vehicle (atv) technology to cross the blood-brain barrier (bbb) and aims to increase target engagement
DNLI Ratings Summary
DNLI Quant Ranking